Bharat Immunologicals (India) Risk Analysis And Volatility Evaluation

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

Macroaxis considers Bharat Immunologicals to be not very risky. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of -0.3108 which signifies that Bharat Immunologicals had -0.3108% of return per unit of standard deviation over the last 1 month. Macroaxis philosophy in foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Bharat Immunologicals Biologicals Corp Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Bharat Immunologicals Mean Deviation of 0.406 and Risk Adjusted Performance of 0.01 to double-check risk estimate we provide.
 Time Horizon     30 Days    Login   to change

Bharat Immunologicals Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. Bharat Immunologicals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Projected Return Density Against Market

Assuming 30 trading days horizon, Bharat Immunologicals has beta of 0.0 . This suggests unless we do not have required data, the returns on DOW and Bharat Immunologicals are completely uncorrelated. Furthermore, Bharat Immunologicals Biologicals Corp LtdIt does not look like Bharat Immunologicals alpha can have any bearing on the equity current valuation.
 Predicted Return Density 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is -321.75. The daily returns are destributed with a variance of 5.05 and standard deviation of 2.25. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 1.54. For similar time horizon, the selected benchmark (DOW) has volatility of 0.0
Alpha over DOW
Beta against DOW=0.00
Overall volatility
Information ratio =0.05

Actual Return Volatility

Bharat Immunologicals Biologicals Corp Ltd accepts 2.2476% volatility on return distribution over the 30 days horizon. DOW inherits 1.4392% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 

Market Risk Breakdown

Bharat Immunologicals Volatility Factors

30 Days Market Risk

Not very risky

Chance of Distress in 24 months

Almost imposible

30 Days Economic Sensitivity

Market Insensitive

Investment Outlook

Bharat Immunologicals Investment Opportunity
Bharat Immunologicals Biologicals Corp Ltd has a volatility of 2.25 and is 1.56 times more volatile than DOW. 20% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is lower than 20 (%) of all global equities and portfolios over the last 30 days.

Volatility Indicators

Bharat Immunologicals Current Risk Indicators
Check also Trending Equities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..